This article presents the devising, development, prototyping and assessment of a wearable arm-ECG sensor system (WAMECG1) for long-term non-invasive heart rhythm monitoring, and functionalities for acquiring, storing, visualizing and transmitting high-quality far-field electrocardiographic signals. The system integrates the main building blocks present in a typical ECG monitoring device such as the skin surface electrodes, front-end amplifiers, analog and digital signal conditioning filters, flash memory and wireless communication capability. These are integrated into a comfortable, easy to wear, and ergonomically designed arm-band ECG sensor system which can acquire a bipolar ECG signal from the upper arm of the user over a period of 72 h. The small-amplitude bipolar arm-ECG signal is sensed by a reusable, long-lasting, Ag–AgCl based dry electrode pair, then digitized using a programmable sampling rate in the range of 125 to 500 Hz and transmitted via Wi-Fi. The prototype comparative performance assessment results showed a cross-correlation value of 99.7% and an error of less than 0.75% when compared to a reference high-resolution medical-grade ECG system. Also, the quality of the recorded far-field bipolar arm-ECG signal was validated in a pilot trial with volunteer subjects from within the research team, by wearing the prototype device while: (a) resting in a chair; and (b) doing minor physical activities. The R-peak detection average sensibilities were 99.66% and 94.64%, while the positive predictive values achieved 99.1% and 92.68%, respectively. Without using any additional algorithm for signal enhancement, the average signal-to-noise ratio (SNR) values were 21.71 and 18.25 for physical activity conditions (a) and (b) respectively. Therefore, the performance assessment results suggest that the wearable arm-band prototype device is a suitable, self-contained, unobtrusive platform for comfortable cardiac electrical activity and heart rhythm logging and monitoring.

Abnormal heart rhythms (arrhythmias) are a major cause of cardiovascular disease and death in Europe. Sudden cardiac death accounts for 50% of cardiac mortality in developed countries; ventricular tachycardia or ventricular fibrillation is the most common underlying arrhythmia. In the ambulatory population, atrial fibrillation is the most common arrhythmia and is associated with an increased risk of stroke and heart failure, particularly in an aging population. Early detection of arrhythmias allows appropriate intervention, reducing disability and death. However, in the early stages of disease arrhythmias may be transient, lasting only a few seconds, and are thus difficult to detect. This work addresses the problem of extracting the far-field heart electrogram signal from noise components, as recorded in bipolar leads along the left arm, using a data driven ECG (electrocardiogram) denoising algorithm based on ensemble empirical mode decomposition (EEMD) methods to enable continuous non-invasive monitoring of heart rhythm for long periods of time using a wrist or arm wearable device with advanced biopotential sensors. Performance assessment against a control denoising method of signal averaging (SA) was implemented in a pilot study with 34 clinical cases. EEMD was found to be a reliable, low latency, data-driven denoising technique with respect to the control SA method, achieving signal-to-noise ratio (SNR) enhancement to a standard closer to the SA control method, particularly on the upper arm-ECG bipolar leads. Furthermore, the SNR performance of the EEMD was improved when assisted with an FFT (fast Fourier transform ) thresholding algorithm (EEMD-fft).

Impedance cardiography (ICG) is a low-cost, non-invasive technique that enables the clinical assessment of haemodynamic parameters, such as cardiac output and stroke volume (SV). Conventional ICG recordings are taken from the patient’s thorax. However, access to ICG vital signs from the upper-arm brachial artery (as an associated surrogate) can enable user-convenient wearable armband sensor devices to provide an attractive option for gathering ICG trend-based indicators of general health, which offers particular advantages in ambulatory long-term monitoring settings. This study considered the upper arm ICG and control Thorax-ICG recordings data from 15 healthy subject cases. A prefiltering stage included a third-order Savitzky–Golay finite impulse response (FIR) filter, which was applied to the raw ICG signals. Then, a multi-stage wavelet-based denoising strategy on a beat-by-beat (BbyB) basis, which was supported by a recursive signal-averaging optimal thresholding adaptation algorithm for Arm-ICG signals, was investigated for robust signal quality enhancement. The performance of the BbyB ICG denoising was evaluated for each case using a 700 ms frame centred on the heartbeat ICG pulse. This frame was extracted from a 600-beat ensemble signal-averaged ICG and was used as the noiseless signal reference vector (gold standard frame). Furthermore, in each subject case, enhanced Arm-ICG and Thorax-ICG above a threshold of correlation of 0.95 with the noiseless vector enabled the analysis of beat inclusion rate (BIR%), yielding an average of 80.9% for Arm-ICG and 100% for Thorax-ICG, and BbyB values of the ICG waveform feature metrics A, B, C and VET accuracy and precision, yielding respective error rates (ER%) of 0.83%, 11.1%, 3.99% and 5.2% for Arm-IG, and 0.41%, 3.82%, 1.66% and 1.25% for Thorax-ICG, respectively. Hence, the functional relationship between ICG metrics within and between the arm and thorax recording modes could be characterised and the linear regression (Arm-ICG vs. Thorax-ICG) trends could be analysed. Overall, it was found in this study that recursive averaging, set with a 36 ICG beats buffer size, was the best Arm-ICG BbyB denoising process, with an average of less than 3.3% in the Arm-ICG time metrics error rate. It was also found that the arm SV versus thorax SV had a linear regression coefficient of determination (R²) of 0.84.